"VIVA19: Unpublished Late-Breaking Clinical Trial Results Announced: IN.PACT AV Access, Lateral Subdermic Plexus Insufficiency, CLOUT, EXTRACT-PE, DISAPEAR"
According to Robert Lookstein, MD, professor of diagnostic, molecular and interventional radiology and surgery at the Icahn School of Medicine at Mount Sinai, “The IN.PACT AV Access randomized trial is an independently adjudicated, prospective, global, multicenter, single-blinded study evaluating the safety and effectiveness of the IN.PACT AV Access drug-coated balloon (DCB; Medtronic) compared to percutaneous transluminal angioplasty (PTA) for the treatment of 330 patients with obstructive lesions (de novo or restenotic) of the native arteriovenous dialysis fistulae (AVF) in the upper extremity.” He added, “As reported at CIRSE 2019, both endpoints were met.”
— Robert A. Lookstein, MD, MHCDL, FSIR, FAHA, FSVM, Professor, Diagnostic, Molecular and Interventional Radiology, Surgery, Icahn School of Medicine at Mount Sinai